Pasw statistics package 18

Manufactured by IBM

Sourced in United States

PASW Statistics Package 18 is a software application designed for statistical analysis. It provides a suite of tools for data management, analysis, and visualization. The core function of this product is to enable users to perform a variety of statistical procedures, including regression, correlation, and hypothesis testing, on their data.

Automatically generated - may contain errors

Lab products found in correlation

Leica dm750 microscope, by Leica camera (1 mentions) Hoxb13, by Santa Cruz Biotechnology (1 mentions) Ventana benchmark system, by Roche (1 mentions) Ultraview universal dab detection kit, by Roche (1 mentions)

2 protocols using pasw statistics package 18

Comparative Antiviral Efficacy and Resistance

Check if the same lab product or an alternative is used in the 5 most similar protocols

For a comparison of the antiviral efficacy, and the frequency of the occurrence of viral breakthrough and genotypic resistance between each treatment group during the study period, an independent samples t-test for continuous data and Fisher’s exact test for categorical data were carried out. The efficacy parameters included serum HBV-DNA and ALT levels. Cumulative HBeAg loss/seroconversion was compared between each treatment group using a log rank test with Kaplan Meier analysis. Statistical analysis was conducted using the PASW statistics package 18 (IBM, Armonk, New York, USA). P-values less than 0.05 were considered significant. Statistical review of this study was performed by a biomedical statistician (Seungho Ryu) affiliated to our institution.

Kim H.J., Park S.K., Yang H.J., Jung Y.S., Park J.H., Park D.I., Cho Y.K., Sohn C.I., Jeon W.K., Kim B.I, & Choi K.Y. (2016). Comparison of the clinical outcomes between antiviral-naïve patients treated with entecavir and lamivudine-resistant patients receiving adefovir add-on lamivudine combination treatment. Clinical and Molecular Hepatology, 22(3), 350-358.

+ Open protocol

+ Expand

IHC Analysis of HOXB2 and HOXB13

Check if the same lab product or an alternative is used in the 5 most similar protocols

The TMA slides were processed in a Ventana Benchmark system (Roche). The primary antibodies used were HOXB2, (Santa Cruz Biotechnology, Santa Cruz CA; 1:200 dilution) and HOXB13 (Santa Cruz Biotechnology, Santa Cruz CA; 1:50 dilution). As a negative control, the primary antibody was replaced with a normal rabbit IgG. The UltraView Universal DAB detection kit was used (Ventana Medical System Inc., Tucson AZ); the slides were dehydrated using ascending-alcohol solutions; cleared in a xylol solution, and mounted in synthetic resin. TMAs were observed in a DM750 Leica microscope (Wetzlar, Germany), and digital images were obtained using the LEZ software; two independent observers evaluated the reaction. The immunostaining intensity was scored in terms of the percentage of positive cells.Data were analyzed using the PASW statistics package 18 (IBM Corp., Armonk, NY, USA).

Gonzalez-Herrera A., Salgado-Bernabe M., Velazquez-Velazquez C., Salcedo-Vargas M., Andrade-Manzano A., Avila-Moreno F, & Pina-Sanchez P. (2015). Increased expression of HOXB2 and HOXB13 proteins is associated with HPV infection and cervical cancer progression. Asian Pacific journal of cancer prevention : APJCP, 16(4).

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!